4-Chloro-7-fluoro-2,3-dihydro-1H-inden-1-one, 97.0%, 250mg

3-(Piperidin-4-yl)benzo[d]isoxazole hydrochloride, 95.0%, 5g

4-(Chloromethyl)-1,3-dioxolan-2-one, 95%, 100mg

Gallic acid, min. 98%, pa, ACS, anhydrous, 500 g, glass packaging

3-O-Ethyl-L-ascorbic acid, 95.0%, 25g

3,6-Dichloropyridazin-4-ol, 95.0%, 1g

(S)-2-((2-Fluorophenoxy)methyl)oxirane, 250mg

1,2-Ethanediamine, N1-[2-(3,4-dichlorophenyl)ethyl]-N1,N2,N2-trimethyl-, hydrobromide (1:2), 100mg

1-cyclohexanecarbonyl-3-methylpiperazine, 95.0%, 2g

1-(Benzofuran-2-yl)-2-bromoethanone, 96%, 5g

2-Hydroxy-4-methyl-5-nitropyridine, 98.0%, 10g

1-(4-Fluorophenyl)-4-(4-methylpiperidin-1-yl)butan-1-one hydrochloride, 95.0%, 250mg

4-[(6-Cyclopropylamino-pyrimidin-4-yl)-methyl-amino]-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg